Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

Ovarian Cancer Heroes Come in Many Forms

March 28th 2019

This week, we spoke with all three of CURE’s 2019 Ovarian Cancer Heroes: Ryan Mitstifer Walton, Paula Anastasia, RN, MN, AOCN, and Shannon Westin, M.D., M.P.H.

Identifying Genetic Similarities in Tumors May Shed Light on Spread of Ovarian Cancer

March 26th 2019

Researchers define the genetic characteristics of ovarian tumors-- information that could lead to new opportunities for personalized therapy and may explain why screening programs for the disease haven’t been successful.

Reflections on Life After Two Prophylactic Surgeries

March 24th 2019

Ten years later, a woman with a BRCA1 mutation finally feels more like herself.

Primary Peritoneal Cancer: Know the Basics

March 22nd 2019

Understand how the rare relative of ovarian cancer is diagnosed and treated.

Ovarian Cancer Screening Tool Should be a Top Research Priority

March 21st 2019

Did we bring this scary, painful, financially draining monster into our lives by eating too many cookies and not doing enough jumping jacks? We need a reliable diagnostic screening tool for ovarian cancer and we need it now.

'Stopping to Smell the Roses' With Olympic Gymnast Shannon Miller

March 21st 2019

In this week’s episode, we spoke with the most decorated Olympic gymnast and ovarian cancer survivor Shannon Miller before CURE’s second annual Ovarian Cancer Heroes gala.

Lenvima Prompts Durable Responses in Ovarian, Endometrial Cancers

March 20th 2019

Lenvima (lenvatinib) in combination with weekly paclitaxel induced activity among those with recurrent endometrial and platinum-resistant epithelial ovarian cancer, according to results from a phase I study.

Triplet Combo Yields Durable Responses in Recurrent Epithelial Ovarian Cancer

March 19th 2019

Treatment with the combination of Keytruda (pembrolizumab), Avastin (bevacizumab) and metronomic cyclophosphamide appeared safe and effective in women with recurrent epithelial ovarian cancer, according to results from an open-label phase 2 study.

Initial PARP Inhibitor Use for Ovarian Cancer May Not Lead to Resistance in Secondary Use

March 18th 2019

Prior exposure to PARP inhibitor treatment may not lead to resistance in future use with these agents in women with recurrent epithelial ovarian cancer, meaning repeat use could become more common.

Individualized Dosing Regimen Reduces Side Effects in Ovarian Cancer Maintenance Therapy

March 18th 2019

Side effects decreased among patients with high-risk ovarian cancer who received an individualized starting dose of Zejula (niraparib), based upon baseline bodyweight and platelet counts, compared with a fixed starting dose.

Zejula Maintenance Therapy Extends Symptom-Free Survival in Recurrent Ovarian Cancer

March 17th 2019

Patients with recurrent ovarian cancer who received Zejula (niraparib) maintenance therapy experienced longer progression-free survival, as well as more time without symptoms or toxicity compared with placebo, according to results from the phase 3 ENGOT-OV16/NOVA trial.

Patients and Their Teams Are Celebrated at the Second Annual Ovarian Cancer Heroes Event

March 16th 2019

The importance of teamwork between patients and their caregivers was a common theme at the second annual Ovarian Cancer Heroes event held in Honolulu, Hawaii.

Scott Foley Opens Up About Caregiving

February 28th 2019

In this week’s episode, we spoke with actor Scott Foley, who opened up about his experience as a caregiver to his mother after her ovarian cancer diagnosis and why he joined the Not on My Watch movement to help educate others.

Friday Frontline: Feb. 22, 2019

February 22nd 2019

From shark genomes to celebs and important updates, here is a quick overview of what is making headlines in the cancer space.

New Movie Tells Gilda Radner's Life Story

February 18th 2019

“Love, Gilda” fea­tures never-before-seen diaries, audio and videotapes from the collection of Gilda Radner, who died at age 42 of ovarian cancer.

At-Home Genetic Testing: Dispelling Fact vs Fiction

February 14th 2019

This week, we spoke with FORCE to dispel some of the misconceptions associated with at-home genetic testing for hereditary cancer risk.

Targeting Ovarian Cancer

February 2nd 2019

Researchers are evaluating the use of folate receptors to treat platinum-resistant ovarian cancer.

Patients With Gynecologic Cancers Want to Discuss Sexual Health

January 25th 2019

Nearly 90 percent of women experienced sexual dysfunction; however, providers were not openly communicating about this side effect, according to survey results.

Alert: Cancer Genetic Testing Should Be Performed in the Health Care Setting

January 22nd 2019

There is a flood of information available about genetic tests for cancer risk in the media, and even at community events, such as health fairs and senior centers. If these promotions have caught your attention and you are considering testing, there is important information that you should know first.

Alisertib-Based Combo Improves Survival Outcomes in Ovarian, Breast Cancer

January 18th 2019

The addition of the investigational drug alisertib to a paclitaxel regimen showed promising activity in patients with recurrent ovarian cancer or advanced breast cancer.

Survey Highlights How 'Much More There Is to a Cancer Diagnosis'

January 17th 2019

A recent survey demonstrated the common tradeoffs most patients report regarding treatment decisions, highlighting the importance of shared decision making.

Cancerversary Prompts Top 10 List of Lessons Learned

January 9th 2019

Rather than revisiting the ghosts of cancer treatments past, I’m focused on using what I’ve learned in three years of active treatment and maintenance for incurable, metastatic cancer.

FDA Approves Lynparza for Maintenance Treatment of BRCA-Mutant Gynecologic Cancers

December 20th 2018

This is the first approval of a PARP inhibitor as a first-line maintenance treatment for BRCA-mutant gynecologic cancers.

FDA Approves Diagnostic Tool for BRCA-Mutant Ovarian Cancer

December 19th 2018

The Food and Drug Administration (FDA) approved BRACAnalysis CDx to be used to identify patients with advanced ovarian cancer who have germline BRCA mutations and are eligible for first line treatment with Lynparza (olaparib) after responding to platinum-based chemotherapy.

Overcoming the Psychological Effects of Ovarian Cancer

December 4th 2018

A new program offers counseling, patient education and vetted referrals to patients and their families.

Lynparza Significantly Delays Progression in Advanced Ovarian Cancer, Study Finds

December 4th 2018

Maintenance treatment with Lynparza (olaparib) after chemotherapy has been found to significantly extend progression-free survival in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation, according to a recent phase 3 study.

Learning the Lingo of Cancer

December 4th 2018

A cancer diagnosis can lead to discussions about family health history, as well as a whole new world to learn about.

Focusing on Quality of Life, Improving Outcomes in Ovarian Cancer

November 27th 2018

Patients with ovarian cancer are living longer than ever.

Legislation Seeks Medicare Recognition of Genetic Counselors to Expand Access to Care

November 26th 2018

To receive payment for counseling and increase access to services, a new bill has been introduced so that genetic counselors receive payment for counseling Medicare beneficiaries.

Giving Teeth to Oral Care

November 17th 2018

Certain cancer treatments can affect the mouth, so dental health should be a lifelong commitment.